{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:49:30Z","timestamp":1793166570475,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ijid.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T01:41:40Z","timestamp":1628473300000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Severe chickenpox disease and seroprevalence in Sweden \u2013 implications for general vaccination"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-0071","authenticated-orcid":false,"given":"K","family":"Widgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-6129","authenticated-orcid":false,"given":"L","family":"Persson Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"M\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tegnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6107-4204","authenticated-orcid":false,"given":"J","family":"Giesecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Studahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.08.012_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/jrms.JRMS_979_17","article-title":"Varicella infection in the Middle East: Prevalence, complications, and vaccination","volume":"23","author":"Al-Turab","year":"2018","journal-title":"J Res Med Sci"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0002","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s12889-019-6795-0","article-title":"Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review","volume":"19","author":"Arlant","year":"2019","journal-title":"BMC Public Health"},{"issue":"42","key":"10.1016\/j.ijid.2021.08.012_bib0003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900233","article-title":"Burden of varicella complications in secondary care, England, 2004 to 2017","volume":"24","author":"Bernal","year":"2019","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jmv.1890300110","article-title":"Antibody response to herpes simplex virus glycoproteins gB and gD","volume":"30","author":"Bernstein","year":"1990","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","article-title":"Belgian Group for V. Varicella paediatric hospitalisations in Belgium: a 1-year national survey","volume":"101","author":"Blumental","year":"2016","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.ijid.2021.08.012_bib0006","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","article-title":"Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents","volume":"164","author":"Bonhoeffer","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"suppl_2","key":"10.1016\/j.ijid.2021.08.012_bib0007","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/infdis\/jiy279","article-title":"Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation","volume":"218","author":"Breuer","year":"2018","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2021.08.012_bib0008","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/INF.0000000000001249","article-title":"Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010","volume":"35","author":"Civen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"18","key":"10.1016\/j.ijid.2021.08.012_bib0009","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijid.2021.08.012_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcv.2006.01.017","article-title":"European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus","volume":"36","author":"de Ory","year":"2006","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.ijid.2021.08.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163636","article-title":"Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models","volume":"11","author":"Del Fava","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0950268806006467","article-title":"Hospital Network for Evaluating Management of Common Childhood D, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era","volume":"135","author":"Dubos","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/jvi.56.1.333-336.1985","article-title":"Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein","volume":"56","author":"Edson","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.08.012_bib0016","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2458-8-372","article-title":"The epidemiology of Varicella Zoster Virus infection in Italy","volume":"8","author":"Gabutti","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2021.08.012_bib0017","series-title":"Varicella Vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines","first-page":"1145","author":"Gershon","year":"2018"},{"issue":"5","key":"10.1016\/j.ijid.2021.08.012_bib0018","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.4049\/jimmunol.1601166","article-title":"Sex Drives Dimorphic Immune Responses to Viral Infections","volume":"198","author":"Ghosh","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/INF.0000000000001347","article-title":"Children Hospitalized With Varicella in Denmark: Sensitivity of the National Patient Register","volume":"36","author":"Glode Helmuth","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.ijid.2021.08.012_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/14760584.2019.1594781","article-title":"Burden of varicella in the Asia-Pacific region: a systematic literature review","volume":"18","author":"Goh","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.ijid.2021.08.012_bib0021","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1017\/S0950268817001777","article-title":"A national register-based study of paediatric varicella hospitalizations in Denmark 2010-2016","volume":"145","author":"Helmuth","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"21","key":"10.1016\/j.ijid.2021.08.012_bib0022","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","article-title":"Varicella in Europe-A review of the epidemiology and experience with vaccination","volume":"33","author":"Helmuth","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0023","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s12879-017-2815-9","article-title":"Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review","volume":"17","author":"Hussey","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.inf.0000195636.43584.bb","article-title":"Seroprevalence of varicella in the French population","volume":"25","author":"Khoshnood","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0042-6822(86)90088-7","article-title":"Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB","volume":"149","author":"Kitamura","year":"1986","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.ijid.2021.08.012_bib0026","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2021.08.012_bib0027","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1386-6532(02)00020-3","article-title":"Acute central nervous system complications in varicella zoster virus infections","volume":"25","author":"Koskiniemi","year":"2002","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.ijid.2021.08.012_bib0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"48","key":"10.1016\/j.ijid.2021.08.012_bib0029","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1016\/j.vaccine.2010.09.017","article-title":"The epidemiology of chickenpox in UK 5-year olds: an analysis to inform vaccine policy","volume":"28","author":"Manikkavasagan","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijid.2021.08.012_bib0030","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/INF.0000000000001656","article-title":"Varicella-related Primary Health-care Visits, Hospitalizations and Mortality in Norway, 2008-2014","volume":"36","author":"Mirinaviciute","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.ijid.2021.08.012_bib0031","doi-asserted-by":"crossref","first-page":"e53511","DOI":"10.1371\/journal.pone.0053511","article-title":"Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009","volume":"7","author":"Morner","year":"2012","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/j.ijid.2021.08.012_bib0032","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region","volume":"25","author":"Nardone","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ijid.2021.08.012_bib0033","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/00365540310015719","article-title":"Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age","volume":"35","author":"Parment","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.08.012_bib0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcv.2009.07.014","article-title":"Varicella-zoster virus CNS disease\u2013viral load, clinical manifestations and sequels","volume":"46","author":"Persson","year":"2009","journal-title":"J Clin Virol"},{"issue":"36","key":"10.1016\/j.ijid.2021.08.012_bib0035","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized vaccinology: A review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ijid.2021.08.012_bib0036","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00183-12","article-title":"Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test","volume":"19","author":"Sauerbrei","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.ijid.2021.08.012_bib0037","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jpeds.2014.06.014","article-title":"Central nervous system complications of varicella-zoster virus","volume":"165","author":"Science","year":"2014","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.ijid.2021.08.012_bib0038","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcv.2006.07.012","article-title":"Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years","volume":"37","author":"Svahn","year":"2006","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0039","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cid\/cit659","article-title":"Chickenpox and risk of stroke: a self-controlled case series analysis","volume":"58","author":"Thomas","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2021.08.012_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13070650","article-title":"Seroprevalence of Antibodies against Measles, Rubella and Varicella among Asylum Seekers Arriving in Lower Saxony, Germany, November 2014-October 2015","volume":"13","author":"Toikkanen","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"10.1016\/j.ijid.2021.08.012_bib0041","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/00365540310013018","article-title":"Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study","volume":"35","author":"Tunback","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0042","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2007.06.002","article-title":"Early acquisition of herpes simplex virus type 1 antibodies in children\u2013a longitudinal serological study","volume":"40","author":"Tunback","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2021.08.012_bib0043","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2334-11-85","article-title":"Hospitalization due to varicella in the Netherlands","volume":"11","author":"van Lier","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2021.08.012_bib0044","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-12-140","article-title":"Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population","volume":"12","author":"van Rijckevorsel","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2021.08.012_bib0045","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.08.012_bib0046","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s12879-016-1957-5","article-title":"The burden of chickenpox disease in Sweden","volume":"16","author":"Widgren","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2021.08.012_bib0015","series-title":"Vaccine Schedules in the European Union","year":"2021"},{"key":"10.1016\/j.ijid.2021.08.012_bib0014","series-title":"Varicella vaccination in the European Union. ECDC Guidance","year":"2014"},{"issue":"25","key":"10.1016\/j.ijid.2021.08.012_bib0047","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221006445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221006445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:01:09Z","timestamp":1761120069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221006445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":47,"alternative-id":["S1201971221006445"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.08.012","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe chickenpox disease and seroprevalence in Sweden \u2013 implications for general vaccination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}